Praluent

Product NDC
61755-021
11-digit product format
617550021
Labeler code
61755
Product ID
61755-021_ad540294-d141-4655-a97b-abc9ae2795a3
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
alirocumab
Dosage form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Labeler
Regeneron Pharmaceuticals, Inc.
Application
BLA125559
Marketing category
BLA
Marketing start
2020-12-01
Substance
ALIROCUMAB
Active strength
150 mg/mL
Pharmacologic classes
Antibodies, Monoclonal [CS], PCSK9 Inhibitor [EPC], PCSK9 Inhibitors [MoA]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Additional Listing Data#

Finished product
Yes
Brand name base
Praluent
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
ALIROCUMAB150 mg/mL

Harmonized Identifiers#

Field, Values table
FieldValues
UniiPP0SHH6V16
Rxcui1659156, 1659161, 1659182, 1659183

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
ab434c1f-2b4e-461c-92e8-506132dea02aProduct name120190716
0ca1d589-929b-4b33-bc5b-1d84abdafa6aProduct name120150324
fc363c46-397b-4476-ac0f-70e43e8e4592Product name120150324

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
61755-021-012024-01-30C16284748780-11030e365-0b1f-111a-e063-dadaa90a10e2These highlights do not include all the information needed to use PRALUENT safely and effectively. See full prescribing information for PRALUENT. PRALUENT ® (alirocumab) injection, for subcutaneous use Initial U.S. Approval: 2015
61755-021-012024-01-30C16284748780-11030e365-0b1f-111a-e063-dadaa90a10e2These highlights do not include all the information needed to use PRALUENT safely and effectively. See full prescribing information for PRALUENT. PRALUENT ® (alirocumab) injection, for subcutaneous use Initial U.S. Approval: 2015
61755-021-022024-01-30C16284748780-11030e365-0b1f-111a-e063-dadaa90a10e2These highlights do not include all the information needed to use PRALUENT safely and effectively. See full prescribing information for PRALUENT. PRALUENT ® (alirocumab) injection, for subcutaneous use Initial U.S. Approval: 2015
61755-021-022024-01-30C16284748780-11030e365-0b1f-111a-e063-dadaa90a10e2These highlights do not include all the information needed to use PRALUENT safely and effectively. See full prescribing information for PRALUENT. PRALUENT ® (alirocumab) injection, for subcutaneous use Initial U.S. Approval: 2015
61755-021-042024-01-30C16284748780-11030e365-0b1f-111a-e063-dadaa90a10e2These highlights do not include all the information needed to use PRALUENT safely and effectively. See full prescribing information for PRALUENT. PRALUENT ® (alirocumab) injection, for subcutaneous use Initial U.S. Approval: 2015
61755-021-042024-01-30C16284748780-11030e365-0b1f-111a-e063-dadaa90a10e2These highlights do not include all the information needed to use PRALUENT safely and effectively. See full prescribing information for PRALUENT. PRALUENT ® (alirocumab) injection, for subcutaneous use Initial U.S. Approval: 2015

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
61755-021-01Praluent1 in 1 CARTONINJECTION, SOLUTION19
61755-021-01Praluent1 mL in 1 SYRINGE, GLASSINJECTION, SOLUTION19
61755-021-02Praluent2 in 1 CARTONINJECTION, SOLUTION29
61755-021-02Praluent1 mL in 1 SYRINGE, GLASSINJECTION, SOLUTION19
61755-021-04Praluent1 in 1 CARTONINJECTION, SOLUTION19
61755-021-04Praluent1 mL in 1 SYRINGE, GLASSINJECTION, SOLUTION19

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
61755-021-01ML - Milliliter61755-021428ec567-5ad9-4e9c-af5a-95c0f5c2751e12022-09-12
61755-021-02ML - Milliliter61755-0218fe87f48-4842-4ee3-8872-37c1df256cf812021-04-08

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
61755-021PRALUENT (ALIROCUMAB) INJECTION, SOLUTION [REGENERON PHARMACEUTICALS, INC.]7Current NDC, Legacy NDC, 6 package rows20240405_7bcfbac2-e8ac-4569-8edc-bcde3b1fd172.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
1659156alirocumab 150 MG in 1 ML Auto-InjectorPSN7bcfbac2-e8ac-4569-8edc-bcde3b1fd1729
1659182alirocumab 75 MG in 1 ML Auto-InjectorPSN7bcfbac2-e8ac-4569-8edc-bcde3b1fd1729
1659161Praluent 150 MG in 1 ML Auto-InjectorPSN7bcfbac2-e8ac-4569-8edc-bcde3b1fd1729
1659183Praluent 75 MG in 1 ML Auto-InjectorPSN7bcfbac2-e8ac-4569-8edc-bcde3b1fd1729
16591611 ML alirocumab 150 MG/ML Auto-Injector [Praluent]SBD7bcfbac2-e8ac-4569-8edc-bcde3b1fd1729
16591831 ML alirocumab 75 MG/ML Auto-Injector [Praluent]SBD7bcfbac2-e8ac-4569-8edc-bcde3b1fd1729
16591561 ML alirocumab 150 MG/ML Auto-InjectorSCD7bcfbac2-e8ac-4569-8edc-bcde3b1fd1729
16591821 ML alirocumab 75 MG/ML Auto-InjectorSCD7bcfbac2-e8ac-4569-8edc-bcde3b1fd1729
16591611 ML Praluent 150 MG/ML Auto-InjectorSY7bcfbac2-e8ac-4569-8edc-bcde3b1fd1729
16591831 ML Praluent 75 MG/ML Auto-InjectorSY7bcfbac2-e8ac-4569-8edc-bcde3b1fd1729
1659156alirocumab 150 MG per 1 ML Auto-InjectorSY7bcfbac2-e8ac-4569-8edc-bcde3b1fd1729
1659182alirocumab 75 MG per 1 ML Auto-InjectorSY7bcfbac2-e8ac-4569-8edc-bcde3b1fd1729
1659161Praluent 150 MG per 1 ML Auto-InjectorSY7bcfbac2-e8ac-4569-8edc-bcde3b1fd1729
1659183Praluent 75 MG per 1 ML Auto-InjectorSY7bcfbac2-e8ac-4569-8edc-bcde3b1fd1729

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startMarketing endSampleExclude flagStatus
61755-021-01617550021011 SYRINGE, GLASS in 1 CARTON (61755-021-01) / 1 mL in 1 SYRINGE, GLASS2020-12-010000-00-00NoNoCurrent
61755-021-02617550021022 SYRINGE, GLASS in 1 CARTON (61755-021-02) / 1 mL in 1 SYRINGE, GLASS2020-12-010000-00-00NoNoCurrent
61755-021-04617550021041 SYRINGE, GLASS in 1 CARTON (61755-021-04) / 1 mL in 1 SYRINGE, GLASS2020-12-010000-00-00YesNoCurrent